Evidence map›Paper›PMID 39386112›Full record

ReviewIJID regions2024

Epidemiological burden of dengue in Sri Lanka: A systematic review of literature from 2000-2020.

LakKumar Fernando, V Pujitha Wickramasinghe, Puneet Kalra, Randee Kastner, Elaine Gallagher

Abstract readReview
In one paragraph

Review in IJID regions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

LakKumar FernandoCentre for Clinical Management of Dengue & Dengue Haemorrhagic Fever, Negombo General Hospital, Negombo, Sri Lanka.
V Pujitha WickramasinghePediatrics, University of Colombo, Colombo, Sri Lanka.
Puneet KalraTakeda Biopharmaceuticals India Private Limited, Gurugram, India.
Randee KastnerTakeda Pharmaceuticals International AG, Zurich, Switzerland.
Elaine GallagherTakeda Pharmaceuticals International AG, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The objective of this systematic literature review (SLR) was to analyze changes in theepidemiological pattern of dengue in Sri Lanka from 2000 to 2020. Methods: The review adhered to Cochrane Handbook and PRISMA guidelines, with data sourced from PubMed, Embase, Cochrane, and DARE. The search focused on English-language publications from 2000 to 2020, using keywords such as dengue epidemiology, incidence, serotype prevalence, and case fatality rates in Sri Lanka. Results: A total of 149 publications (68 peer-reviewed and 81 grey literature sources) were included. Findings confirmed that dengue is endemic in Sri Lanka, with a marked increase in cases during major epidemics. The highest incidences were recorded in 2017 (186,101 cases) and 2019 (105,049 cases). Among the affected districts Colombo and Gampaha have the highest notification rates. The disease is reported year-round, with peaks during the monsoon seasons. From 2012 to 2019, the most affected age groups were 25-49-year-olds, followed by younger demographics. All four DENV serotypes cocirculated, with DENV-2 dominating since 2017. Case fatality rates ranged from 0.11% to 1.0%, peaking in 2009. Conclusions: This review underscores the rising burden of dengue in Sri Lanka, highlighting the need for enhanced surveillance, prevention strategies, and potential vaccination to curb its spread.

Indexed as

DengueEpidemiologySri Lanka

Identifiers

PMID39386112
PMCPMC11462220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.